Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore

Clinical Therapeutics

Volumn 36, Issue 7, 2014, Pages 1043-1053

  Cheen, Hua Heng McVin ^a,b   Lim, Seng Han ^a   Huang, Ming Chien ^b   Bee, Yong Mong ^a   Wee, Hwee Lin ^b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

compliance; diabetes mellitus; insulin; medication adherence; persistence

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

ADULT; ARTICLE; COMPARATIVE EFFECTIVENESS; DIABETES MELLITUS; FEMALE; HUMAN; INSULIN INJECTION PEN; INSULIN INJECTION VIAL SYRINGE; INSULIN TREATMENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POLYPHARMACY; RETROSPECTIVE STUDY; SINGAPORE; SYRINGE; AGED; COMPARATIVE STUDY; DEVICES; DIABETES MELLITUS, TYPE 2; DISPOSABLE EQUIPMENT; INJECTION; MIDDLE AGED; STATISTICS; STATISTICS AND NUMERICAL DATA; UTILIZATION;

AGED; DIABETES MELLITUS, TYPE 2; DISPOSABLE EQUIPMENT; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS; INSULIN; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RETROSPECTIVE STUDIES; SINGAPORE; STATISTICS AS TOPIC; SYRINGES;

EID: 84904805406     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2014.05.009     Document Type: Article

References (41)

1. N. Iqbal The burden of type 2 diabetes: strategies to prevent or delay onset Vasc Health Risk Manag 3 2007 511 520
2. G. Danaei, M.M. Finucane, and Y. Lu et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants Lancet 378 2011 31 40
3. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 1998 539 553
4. National diabetes statistics, 2011. http://professional.diabetes.org/ admin/UserFiles/0%20-%20Sean/FastFacts%20March%202013.pdf. Last accessed September 8, 2013.
5. S. Del Prato, G. Penno, and R. Miccoli Changing the treatment paradigm for type 2 diabetes Diabetes Care 32 Suppl 2 2009 S217 S222
6. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
7. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
8. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
9. American Diabetes Association Standards of medical care in diabetes: 2013 Diabetes Care 36 Suppl 1 2013 S11 S66
10. M. Marre Before oral agents fail: the case for starting insulin early Int J Obes Relat Metab Disord 26 Suppl 3 2002 S25 S30
11. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics, Division of Health Interview Statistics, data from the National Health Interview Survey. Age-adjusted percentage of adults with diabetes using diabetes medication, by type of medication, United States, 1997-2011 Updated November 20, 2012. http://www.cdc.gov/diabetes/statistics/ meduse/fig2.htm. Last accessed September 8, 2013.
12. E. Buysman, C. Conner, and M. Aagren et al. Adherence and persistence to a regimen of basal insulin in a pre-filled pen compared to vial/syringe in insulin-naive patients with type 2 diabetes Curr Med Res Opin 27 2011 1709 1717
13. J.A. Cramer A systematic review of adherence with medications for diabetes Diabetes Care 27 2004 1218 1224
14. D.L. Sackett, R.B. Haynes, and E.S. Gibson et al. Randomised clinical trial of strategies for improving medication compliance in primary hypertension Lancet 1 1975 1205 1207
15. W.C. Lee, S. Balu, and D. Cobden et al. Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review Manag Care Interface 19 2006 31 41
16. M. Pladevall, L.K. Williams, and L.A. Potts et al. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes Diabetes Care 27 2004 2800 2805
17. C.J. Currie, M. Peyrot, and C.L. Morgan et al. The impact of treatment noncompliance on mortality in people with type 2 diabetes Diabetes Care 35 2012 1279 1284
18. P.S. Odegard, and K. Capoccia Medication taking and diabetes: a systematic review of the literature Diabetes Educ 33 2007 1014 1029
19. W.H. Polonsky, T.R. Hajos, M.P. Dain, and F.J. Snoek Are patients with type 2 diabetes reluctant to start insulin therapy? an examination of the scope and underpinnings of psychological insulin resistance in a large, international population Curr Med Res Opin 27 2011 1169 1174
20. W.H. Polonsky Emotional and quality-of-life aspects of diabetes management Curr Diab Rep 2 2002 153 159
21. M. Peyrot, A.H. Barnett, L.F. Meneghini, and P.M. Schumm-Draeger Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study Diabet Med 29 2012 682 689
22. C. Molife, L.J. Lee, and L. Shi et al. Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe Diabetes Technol Ther 11 2009 529 538
23. C.V. Asche, L. Shane-McWhorter, and S. Raparla Health economics and compliance of vials/syringes versus pen devices: a review of the evidence Diabetes Technol Ther 12 Suppl 1 2010 S101 S108
24. R.E. Rakel Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy Adv Ther 26 2009 838 846
25. J.G. Hamilton Needle phobia: a neglected diagnosis J Fam Pract 41 1995 169 175
26. L.J. Lee, Q. Li, and M.W. Reynolds et al. Comparison of utilization, cost, adherence, and hypoglycemia in patients with type 2 diabetes initiating rapid-acting insulin analog with prefilled pen versus vial/syringe J Med Econ 14 2011 75 86
27. L. Niskanen A clinical and health economic review of a prefilled insulin pen CurrMed Res Opin 26 2010 2431 2439
28. M.D. Pawaskar, F.T. Camacho, and R.T. Anderson et al. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis Clin Ther 29 2007 1294 1305
29. L. Osterberg, and T. Blaschke Adherence to medication N Engl J Med 353 2005 487 497
30. L.M. Hess, M.A. Raebel, D.A. Conner, and D.C. Malone Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures Ann Pharmacother 40 2006 1280 1288
31. J.H. Flaherty, H.M. Perry III, G.S. Lynchard, and J.E. Morley Polypharmacy and hospitalization among older home care patients J Gerontol. AbiolSciMedSci 55 2000 M554 M559
32. L. Xie, S. Zhou, and W. Wei et al. Does pen help? a real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus Diabetes Technol Ther 15 2013 230 236
33. M.H. Cheen, M.C. Kong, and R.F. Zhang et al. Adherence to osteoporosis medications amongst Singaporean patients Osteoporos Int 23 2012 1053 1060
34. Ministry of Health Singapore. Costs and financing. Updated May 13, 2013. http://www.moh.gov.sg/content/moh-web/home/costs-and-financing.html. Accessed October 29, 2013.
35. D.P. Nau Recommendations for improving adherence to type 2 diabetes mellitus therapy: focus on optimizing oral and non-insulin therapies Am J Manag Care 18 2012 S49 S54
36. World Health Organization. Adherence to long-term therapies: evidence for action. http://apps.who.int/medicinedocs/en/d/Js4883e/8.4.5.html#Js4883e.8.4.5. Accessed October 29, 2013.
37. R. van Bruggen, K. Gorter, and R.P. Stolk et al. Refill adherence and polypharmacy among patients with type 2 diabetes in general practice Pharmacoepidemiol Drug Saf 18 2009 983 991
38. R.W. Grant, N.G. Devita, D.E. Singer, and J.B. Meigs Polypharmacy and medication adherence in patients with type 2 diabetes Diabetes Care 26 2003 1408 1412
39. C.M. Hughes Medication non-adherence in the elderly: how big is the problem? Drugs Aging 21 2004 793 811
40. I. Hartman Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence Clin Med Res 6 2008 54 67
41. M. Korytkowski, D. Bell, C. Jacobsen, and R. Suwannasari FlexPen Study Team. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus Clin Ther 25 2003 2836 2848